179 related articles for article (PubMed ID: 31881010)
1. Circadian clock associates with tumor microenvironment in thoracic cancers.
Yang Y; Yuan G; Xie H; Wei T; Zhu D; Cui J; Liu X; Shen R; Zhu Y; Yang X
Aging (Albany NY); 2019 Dec; 11(24):11814-11828. PubMed ID: 31881010
[TBL] [Abstract][Full Text] [Related]
2. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
Xian H; Li Y; Zou B; Chen Y; Yin H; Li X; Pan Y
BMC Cancer; 2022 Jan; 22(1):107. PubMed ID: 35078435
[TBL] [Abstract][Full Text] [Related]
3. Research on circadian clock genes in non-small-cell lung carcinoma.
Qiu M; Chen YB; Jin S; Fang XF; He XX; Xiong ZF; Yang SL
Chronobiol Int; 2019 Jun; 36(6):739-750. PubMed ID: 31014124
[TBL] [Abstract][Full Text] [Related]
4. Circadian clock is associated with tumor microenvironment in kidney renal clear cell carcinoma.
Zhou L; Luo Z; Li Z; Huang Q
Aging (Albany NY); 2020 Jul; 12(14):14620-14632. PubMed ID: 32681792
[TBL] [Abstract][Full Text] [Related]
5. Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes.
van der Watt PJ; Roden LC; Davis KT; Parker MI; Leaner VD
Mol Cancer Res; 2020 Sep; 18(9):1340-1353. PubMed ID: 32503923
[TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Analysis Reveals Disrupted Circadian Clock Associates With T Cell Exhaustion.
Wu Y; Tao B; Zhang T; Fan Y; Mao R
Front Immunol; 2019; 10():2451. PubMed ID: 31708917
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors.
Jang HJ; Lee HS; Ramos D; Park IK; Kang CH; Burt BM; Kim YT
J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1598-1610.e3. PubMed ID: 31879171
[TBL] [Abstract][Full Text] [Related]
8. Circadian clock: a regulator of the immunity in cancer.
Zhang Z; Zeng P; Gao W; Zhou Q; Feng T; Tian X
Cell Commun Signal; 2021 Mar; 19(1):37. PubMed ID: 33752691
[TBL] [Abstract][Full Text] [Related]
9. Chronopharmacological strategies focused on chrono-drug discovery.
Ohdo S; Koyanagi S; Matsunaga N
Pharmacol Ther; 2019 Oct; 202():72-90. PubMed ID: 31173839
[TBL] [Abstract][Full Text] [Related]
10. T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment.
Cai MC; Zhao X; Cao M; Ma P; Chen M; Wu J; Jia C; He C; Fu Y; Tan L; Xue X; Yu Z; Zhuang G
J Pathol; 2020 Jun; 251(2):147-159. PubMed ID: 32222046
[TBL] [Abstract][Full Text] [Related]
11. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
12. Circadian regulation of cancer cell and tumor microenvironment crosstalk.
Xuan W; Khan F; James CD; Heimberger AB; Lesniak MS; Chen P
Trends Cell Biol; 2021 Nov; 31(11):940-950. PubMed ID: 34272133
[TBL] [Abstract][Full Text] [Related]
13. Circadian clock and cell cycle: Cancer and chronotherapy.
Yao J; He C; Zhao W; Hu N; Long D
Acta Histochem; 2021 Dec; 123(8):151816. PubMed ID: 34800857
[TBL] [Abstract][Full Text] [Related]
14. Glucose restriction induces AMPK-SIRT1-mediated circadian clock gene Per expression and delays NSCLC progression.
Li B; Chen Q; Feng Y; Wei T; Zhong Y; Zhang Y; Feng Q
Cancer Lett; 2023 Nov; 576():216424. PubMed ID: 37778683
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis of the prognosis and therapeutic significance of circadian clock in ovarian cancer.
Zhu J; Zhou Q; Pan M; Zhou C
Gene; 2021 Jul; 788():145644. PubMed ID: 33848579
[TBL] [Abstract][Full Text] [Related]
16. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
17. Timing gone awry: distinct tumour suppressive and oncogenic roles of the circadian clock and crosstalk with hypoxia signalling in diverse malignancies.
Chang WH; Lai AG
J Transl Med; 2019 Apr; 17(1):132. PubMed ID: 31014368
[TBL] [Abstract][Full Text] [Related]
18. Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.
Mocellin S; Tropea S; Benna C; Rossi CR
BMC Med; 2018 Feb; 16(1):20. PubMed ID: 29455641
[TBL] [Abstract][Full Text] [Related]
19. The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.
Ye Y; Xiang Y; Ozguc FM; Kim Y; Liu CJ; Park PK; Hu Q; Diao L; Lou Y; Lin C; Guo AY; Zhou B; Wang L; Chen Z; Takahashi JS; Mills GB; Yoo SH; Han L
Cell Syst; 2018 Mar; 6(3):314-328.e2. PubMed ID: 29525205
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the Molecular Circadian Clock and Cancer: An Epigenetic Link.
Hernández-Rosas F; López-Rosas CA; Saavedra-Vélez MV
Biochem Genet; 2020 Feb; 58(1):189-209. PubMed ID: 31552565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
